fbpx
Wikipedia

4'-Hydroxynorendoxifen

4'-Hydroxynorendoxifen is a synthetic, nonsteroidal antiestrogen of the triphenylethylene group.[1][2] It is a dual selective estrogen receptor modulator (SERM) and aromatase inhibitor (AI), and was derived from tamoxifen, a SERM, and norendoxifen, a metabolite of tamoxifen that has been found to act as an AI.[1][2] The drug has been suggested for potential development as a treatment for estrogen receptor (ER)-positive breast cancer.[1][2] It was synthesized in 2015.[1]

4'-Hydroxynorendoxifen
Clinical data
Other namesN,N-Didesmethyl-4,4'-dihydroxytamoxifen
Identifiers
  • 4,4'-(1-(4-(2-Aminoethoxy)phenyl)but-1-ene-1,2-diyl)diphenol
ChemSpider
  • 58967386
Chemical and physical data
FormulaC24H25NO3
Molar mass375.468 g·mol−1
3D model (JSmol)
  • Interactive image
  • CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCN)C=C1)C1=CC=C(O)C=C1
  • InChI=1S/C24H25NO3/c1-2-23(17-3-9-20(26)10-4-17)24(18-5-11-21(27)12-6-18)19-7-13-22(14-8-19)28-16-15-25/h3-14,26-27H,2,15-16,25H2,1H3
  • Key:VYSGWFCGFKTGQC-UHFFFAOYSA-N

References edit

  1. ^ a b c d Lv W, Liu J, Skaar TC, Flockhart DA, Cushman M (March 2015). "Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities". Journal of Medicinal Chemistry. 58 (6): 2623–48. doi:10.1021/jm501218e. PMC 4687028. PMID 25751283.
  2. ^ a b c Nagini S (2017). "Breast Cancer: Current Molecular Therapeutic Targets and New Players". Anti-Cancer Agents in Medicinal Chemistry. 17 (2): 152–163. doi:10.2174/1871520616666160502122724. PMID 27137076.

hydroxynorendoxifen, synthetic, nonsteroidal, antiestrogen, triphenylethylene, group, dual, selective, estrogen, receptor, modulator, serm, aromatase, inhibitor, derived, from, tamoxifen, serm, norendoxifen, metabolite, tamoxifen, that, been, found, drug, been. 4 Hydroxynorendoxifen is a synthetic nonsteroidal antiestrogen of the triphenylethylene group 1 2 It is a dual selective estrogen receptor modulator SERM and aromatase inhibitor AI and was derived from tamoxifen a SERM and norendoxifen a metabolite of tamoxifen that has been found to act as an AI 1 2 The drug has been suggested for potential development as a treatment for estrogen receptor ER positive breast cancer 1 2 It was synthesized in 2015 1 4 HydroxynorendoxifenClinical dataOther namesN N Didesmethyl 4 4 dihydroxytamoxifenIdentifiersIUPAC name 4 4 1 4 2 Aminoethoxy phenyl but 1 ene 1 2 diyl diphenolChemSpider58967386Chemical and physical dataFormulaC 24H 25N O 3Molar mass375 468 g mol 13D model JSmol Interactive imageSMILES CCC C C1 CC C O C C1 C1 CC C OCCN C C1 C1 CC C O C C1InChI InChI 1S C24H25NO3 c1 2 23 17 3 9 20 26 10 4 17 24 18 5 11 21 27 12 6 18 19 7 13 22 14 8 19 28 16 15 25 h3 14 26 27H 2 15 16 25H2 1H3Key VYSGWFCGFKTGQC UHFFFAOYSA NReferences edit a b c d Lv W Liu J Skaar TC Flockhart DA Cushman M March 2015 Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities Journal of Medicinal Chemistry 58 6 2623 48 doi 10 1021 jm501218e PMC 4687028 PMID 25751283 a b c Nagini S 2017 Breast Cancer Current Molecular Therapeutic Targets and New Players Anti Cancer Agents in Medicinal Chemistry 17 2 152 163 doi 10 2174 1871520616666160502122724 PMID 27137076 nbsp This antineoplastic or immunomodulatory drug article is a stub You can help Wikipedia by expanding it vte Retrieved from https en wikipedia org w index php title 4 27 Hydroxynorendoxifen amp oldid 1130352576, wikipedia, wiki, book, books, library,

article

, read, download, free, free download, mp3, video, mp4, 3gp, jpg, jpeg, gif, png, picture, music, song, movie, book, game, games.